Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer

Neoadjuvant chemotherapy with docetaxel, oxaliplatin, fluorouracil, and leucovorin (FLOT regimen) has shown promising results in terms of pathological response and survival rate in patients with locally advanced resectable gastric cancer (LAGC). However, tegafur gimeracil oteracil potassium capsule...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Commun
Main Authors: Sah, Birendra Kumar, Zhang, Benyan, Zhang, Huan, Li, Jian, Yuan, Fei, Ma, Tao, Shi, Min, Xu, Wei, Zhu, Zhenglun, Liu, Wentao, Yan, Chao, Li, Chen, Liu, Bingya, Yan, Min, Zhu, Zhenggang
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7705676/
https://ncbi.nlm.nih.gov/pubmed/33257672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-020-19965-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados